Epidemiological monitoring and control perspectives: application of a parsimonious modelling framework to the COVID-19 dynamics in France

SARS-Cov-2 virus has spread over the world creating one of the fastest pandemics ever. The absence of immunity, asymptomatic transmission, and the relatively high level of virulence of the COVID-19 infection it causes led to a massive flow of patients in intensive care units (ICU). This unprecedented situation calls for rapid and accurate mathematical models to best inform public health policies. We develop an original parsimonious model that accounts for the effect of the age of infection on the natural history of the disease. Analysing the ongoing COVID-19 in France, we estimate the value of the key epidemiological parameters, such as the basic reproduction number (R0), and the efficiency of the national control strategy. We then use our deterministic model to explore several scenarios posterior to lock-down lifting and compare the efficiency of non pharmaceutical interventions (NPI) described in the literature.

[1]  N. Linton,et al.  Serial interval of novel coronavirus (COVID-19) infections , 2020, International Journal of Infectious Diseases.

[2]  M. Keeling,et al.  Modeling Infectious Diseases in Humans and Animals , 2007 .

[3]  M. Keeling,et al.  The effects of local spatial structure on epidemiological invasions , 1999, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[4]  C. Whittaker,et al.  Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand , 2020 .

[5]  Yazdan Yazdanpanah,et al.  Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists , 2020, Intensive Care Medicine.

[6]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[7]  J. Lessler,et al.  Estimating the burden of SARS-CoV-2 in France , 2020, Science.

[8]  Benjamin M. Bolker,et al.  Ecological Models and Data in R , 2008 .

[9]  Christl A. Donnelly,et al.  Report 2: Estimating the potential total number of novel Coronavirus cases in Wuhan City, China , 2020 .

[10]  M. Olfson,et al.  Lockdown exit strategies and risk of a second epidemic peak: a stochastic agent-based model of SARS-CoV-2 epidemic in France , 2020, medRxiv.

[11]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[12]  M. T. Sofonea,et al.  Optimal COVID-19 epidemic control until vaccine deployment , 2020, medRxiv.

[13]  Pierre Magal,et al.  Predicting the number of reported and unreported cases for the COVID-19 epidemic in South Korea, Italy, France and Germany , 2020, medRxiv.

[14]  I. J. Douglas,et al.  OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. , 2020, medRxiv.

[15]  Ruiyun Li,et al.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) , 2020, Science.

[16]  S. Soubeyrand,et al.  Effect of a one-month lockdown on the epidemic dynamics of COVID-19 in France , 2020, medRxiv.

[17]  A. M. Leontovich,et al.  The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.

[18]  Jonathan Le Roux,et al.  COVID-19: One-month impact of the French lockdown on the epidemic burden , 2020, medRxiv.

[19]  S. S. Wilks.  The Large-Sample Distribution of the Likelihood Ratio for Testing Composite Hypotheses , 1938 .

[20]  Y. Michalakis,et al.  Early phylodynamics analysis of the COVID-19 epidemics in France , 2020, medRxiv.

[21]  V. Colizza,et al.  Expected impact of lockdown in Île-de-France and possible exit strategies , 2020, medRxiv.

[22]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[23]  C. Whittaker,et al.  Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.

[24]  P. Klepac,et al.  Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts , 2020, The Lancet Global Health.

[25]  Don Klinkenberg,et al.  Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[26]  W. O. Kermack,et al.  A contribution to the mathematical theory of epidemics , 1927 .

[27]  N. Linton,et al.  Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data , 2020, medRxiv.